Understanding trends in end-of-life care for bladder cancer patients is essential in improving palliative care planning. This study analyzes trends in preferred place of death among bladder cancer patients in the United States from year 2000 to 2020.
Data from the CDC WONDER database were used to identify 293,906 deaths caused by bladder cancer. Further data on patient place of death, age, demographics, census geographic region, and year of death were recorded. Place of death was used as a proxy for preferred place of death. A multivariable binary logistic regression analysis was performed to determine associations between preferred place of death and other variables.
At-home deaths were most common among individuals aged 75-84 years of age (42,644 deaths) and 85+ years of age (32,806 deaths). Hospice use was highest among the 75-84 age group (8,754 deaths) and 85+ age group (7,358 deaths). Nursing home deaths were highest in the 85+ age group (26,216 deaths), with significant age-related differences (p < 0.001). In terms of racial variations, White individuals accounted for 93.6% of all deaths. Black individuals were less likely to utilize hospice care (p < 0.001). Overall, race differences were significantly associated with place of death (p < 0.001). The number of home deaths rose from 4,281 in 2000 to 8,554 in 2020, and hospice deaths also rose significantly during this time period. Interestingly, younger individuals were more likely to die in hospice compared to those aged 85 years or older, though the odds decreased with age. Black individuals had significantly lower odds of hospice use than White patients (OR = 0.699, p < 0.001) and hospice use increased annually by an average of 13.4% (p < 0.001).
The results indicate that utilization of hospice care and home-based end-of-life care have risen in prominence though disparities are present across racial and regional groups. Further studies are needed to better understand potential barriers to end-of-life care among bladder cancer patients.
Palliative & supportive care. 2026 Apr 15*** epublish ***
Manas Pustake, Atharva Railkar, Mohammad Arfat Ganiyani, Atulya Aman Khosla, Avi Harisingani, Hanzala Jehangir, Mostafa Eysha, Divya Samat, Taha Hassan, Rohan Garje
Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA., Department of Medical Oncology, Miami Cancer Institute, Miami, Florida, USA., Department of Hematology and Oncology, Mayo Clinic Jacksonville, Jacksonville, Florida, USA., Department of Internal Medicine, Loyola MacNeal Hospital, Berwyn, Illinois, USA., Department of Internal Medicine, Rutgers Health Trinitas Regional Medical Center, Elizabeth, New Jersey, USA., Department of Internal Medicine, Tower Health Reading Hospital, West Reading, Pennsylvania, USA., Department of Internal Medicine, Texas Tech University Health Sciences Center Amarillo, Amarillo, Texas, USA.